Altamir - 2018 Registration document

1

Business description and activities

Presentation of the Company

46.5 m

54.1 m

5.4 % % of the portfolio at fair value

Residual cost (in €m)

Fair value (in €m)

HEALTHCARE • 9 other companies

Annual turnover (in €m)

Company

Country Business description

Amplitude Surgical is a listed French company, leader on the global surgical technology market for lower-limb orthopaedics. The company develops and markets high-end solutions for orthopaedic surgery covering the main disorders affecting the hip, knee and extremities (foot and ankle). A leading player in France, Amplitude Surgical has around420 employees andmarkets its products in more than 30 countries. With a presence in 12 countries, Unilabs is a European leader in diagnostic services and the only provider able to offer services in laboratory medicine (80%of EBITDA), imagingandpathology. Its customers arepublic andprivate healthcare providers (hospitals, general practitioners, occupational health units), country councils, insurance companies and outpatients, as well as the pharmaceutical industry and clinical research organisations. Unilabs has around 10,500 employees (including 1,000 doctors) and generates over €900m in revenues, mainly in Switzerland, France, the Iberian Peninsula and Scandinavia. Based in the United States, Candela is a leading global provider of non- surgical aesthetic devices. The company offers leading-edge solutions for a wide range of medical-aesthetic treatments including body contouring, hair removal, wrinkle reduction, tattoo removal, women’s health, improving skin appearance by treating benign superficial vascular and pigmentary lesions, as well as the treatment of acne, varicose veins and cellulite.

103

FRANCE

www.amplitude-surgical.com

956

SWITZERLAND

www.unilabs.fr

299 *

UNITED STATES

www.syneron-candela.com

Vyaire Medical is a carve-out of the Respiratory Solutions Business of US group Becton Dickinson. Vyaire Medical is the world leader in respiratory diagnostics, ventilation and post-anaesthesia monitoring.

749 *

UNITED STATES

www.vyaire.com

Neuraxpharm (formerly NuPharm) is a pan-European leader in the manufacture of branded and generic pharmaceutical products focused on the treatment of central nervous systemdisorders. The companywas formed from themerger of NeuraxpharmArzneimittel inGermany and Invent Farma in Spain, and has had a presence in five European countries including France since 2018, following the purchase of Laboratoire Biodim.

216

GERMANY

www.neuraxpharm.com

* Revenues converted into millions of euros based on exchange rates at 31/12/2018.

42 Registration document ALTAMIR 2018

www.altamir.fr

Made with FlippingBook - Online Brochure Maker